Cameron Turtle - Net Worth and Insider Trading
Cameron Turtle Net Worth
The estimated net worth of Cameron Turtle is at least $66 Million dollars as of 2026-08-12. Cameron Turtle is the CEO of Spyre Therapeutics Inc and owns about 567,540 shares of Spyre Therapeutics Inc (SYRE) stock worth over $58 Million. Cameron Turtle is the Chief Business Officer of Eidos Therapeutics Inc and owns about 50,621 shares of Eidos Therapeutics Inc (EIDX) stock worth over $6 Million. Cameron Turtle is also the See Remarks of BridgeBio Pharma Inc and owns about 12,568 shares of BridgeBio Pharma Inc (BBIO) stock worth over $1 Million. Details can be seen in Cameron Turtle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cameron Turtle has not made any transactions after 2026-08-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cameron Turtle
Cameron Turtle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cameron Turtle owns 5 companies in total, including BridgeBio Pharma Inc (BBIO) , Eidos Therapeutics Inc (EIDX) , and Spyre Therapeutics Inc (SYRE) among others .
Click here to see the complete history of Cameron Turtle’s form 4 insider trades.
Insider Ownership Summary of Cameron Turtle
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| BBIO | BridgeBio Pharma Inc | 2020-12-28 | See Remarks |
| EIDX | Eidos Therapeutics Inc | 2020-12-15 | Chief Business Officer |
| SYRE | Spyre Therapeutics Inc | 2026-07-01 | Chief Operating Officer |
 | | 2025-06-02 | director |
| | 2026-03-23 | director |
Cameron Turtle Latest Holdings Summary
Cameron Turtle currently owns a total of 3 stocks. Among these stocks, Cameron Turtle owns 567,540 shares of Spyre Therapeutics Inc (SYRE) as of August 3, 2026, with a value of $58 Million and a weighting of 88.96%. Cameron Turtle owns 50,621 shares of Eidos Therapeutics Inc (EIDX) as of December 15, 2020, with a value of $6 Million and a weighting of 9.44%. Cameron Turtle also owns 12,568 shares of BridgeBio Pharma Inc (BBIO) as of December 28, 2020, with a value of $1 Million and a weighting of 1.6%.
Latest Holdings of Cameron Turtle
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics Inc | 2026-08-03 | 567,540 | 102.74 | 58,309,060 |
| EIDX | Eidos Therapeutics Inc | 2020-12-15 | 50,621 | 122.21 | 6,186,392 |
| BBIO | BridgeBio Pharma Inc | 2020-12-28 | 12,568 | 83.70 | 1,051,942 |
Holding Weightings of Cameron Turtle
Cameron Turtle Form 4 Trading Tracker
According to the SEC Form 4 filings, Cameron Turtle has made a total of 9 transactions in Spyre Therapeutics Inc (SYRE) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Spyre Therapeutics Inc is the sale of 15,000 shares on August 3, 2026, which brought Cameron Turtle around $1 Million.
According to the SEC Form 4 filings, Cameron Turtle has made a total of 0 transactions in Eidos Therapeutics Inc (EIDX) over the past 5 years. The most-recent trade in Eidos Therapeutics Inc is the sale of 26,294 shares on December 15, 2020, which brought Cameron Turtle around $3 Million.
According to the SEC Form 4 filings, Cameron Turtle has made a total of 0 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years. The most-recent trade in BridgeBio Pharma Inc is the sale of 19,500 shares on December 28, 2020, which brought Cameron Turtle around $1 Million.
Insider Trading History of Cameron Turtle
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Cameron Turtle Trading Performance
Cameron Turtle Ownership Network
Ownership Network List of Cameron Turtle
Ownership Network Relation of Cameron Turtle
Cameron Turtle Owned Company Details
What does BridgeBio Pharma Inc do?
Who are the key executives at BridgeBio Pharma Inc?
Cameron Turtle is the See Remarks of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include Chief Accounting Officer Maricel Apuli , director & See Remarks Neil Kumar , and President and COO Thomas Trimarchi .
BridgeBio Pharma Inc (BBIO) Insider Trades Summary
Over the past 18 months, Cameron Turtle made no insider transaction in BridgeBio Pharma Inc (BBIO). Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 1,454,178 shares made by Neil Kumar , a net sale of 86,517 shares made by Hannah Valantine , and a net sale of 10,536 shares made by Maricel Apuli .
In summary, during the past 3 months, insiders sold 432,117 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 432,117 shares. During the past 18 months, 18,545,731 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 18,545,731 shares.
BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
BridgeBio Pharma Inc Insider Transactions
Cameron Turtle Mailing Address
Above is the net worth, insider trading, and ownership report for Cameron Turtle. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Cameron Turtle's mailing address is: Waltham Ma 02453.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
